| Application no. and date | 14194507.1 (espacenet) (Federated) (European Patent Register), 20040730 | | Patent/reg. no. and date | DK/EP 2896397, 20170906 | | Publication date | 20150722 | | Priority no. and date | US 491534 P, 20030801 | | EP pub. no. and date |
EP 2896397 20150722 | | Effective date | | | Applicant/owner | Mitsubishi Tanabe Pharma Corporation, 3-2-10, Dosho-machi, Chuo-ku
Osaka-shi
Osaka 541-8505, JP | | Applicant ref. no. | BBS149861EPDK | | Inventor | Nomura, Sumihiro, c/o Mitsubishi Tanabe Pharma Corporation
3-2-10, Dosho-machi
Chuo-ku
Osaka-shi
Osaka 541-8505, JP,
Kawanishi, Eiji, c/o Mitsubishi Tanabe Pharma Corporation
3-2-10, Dosho-machi
Chuo-ku
Osaka-shi
Osaka 541-8505, JP,
Ueta, Kiichiro, c/o Mitsubishi Tanabe Pharma Corporation
3-2-10, Dosho-machi
Chuo-ku
Osaka-shi
Osaka 541-8505, JP | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/351 (2006.01) , A61K 31/70 (2006.01) , C07D 309/12 (2006.01) , C07H 19/06 (2006.01) | | Title | Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
